Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides

To learn more about the structure&#8722;activity relationships of (<i>E</i>)-3-(5-styryl-1,3,4-oxadiazol-2-yl)benzenesulfonamide derivatives, which in our previous research displayed promising in vitro anticancer activity, we have synthesized a group of novel (<i>E</i>)-5...

Full description

Bibliographic Details
Main Authors: Krzysztof Szafrański, Jarosław Sławiński, Łukasz Tomorowicz, Anna Kawiak
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/6/2235
id doaj-50862adfbcfc4a9ebe25d2e00bfa7ea0
record_format Article
spelling doaj-50862adfbcfc4a9ebe25d2e00bfa7ea02020-11-25T01:44:36ZengMDPI AGInternational Journal of Molecular Sciences1422-00672020-03-01216223510.3390/ijms21062235ijms21062235Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamidesKrzysztof Szafrański0Jarosław Sławiński1Łukasz Tomorowicz2Anna Kawiak3Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416 Gdańsk, PolandDepartment of Organic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416 Gdańsk, PolandDepartment of Organic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416 Gdańsk, PolandDepartment of Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, ul. Abrahama 58, 80-307 Gdańsk, PolandTo learn more about the structure&#8722;activity relationships of (<i>E</i>)-3-(5-styryl-1,3,4-oxadiazol-2-yl)benzenesulfonamide derivatives, which in our previous research displayed promising in vitro anticancer activity, we have synthesized a group of novel (<i>E</i>)-5-[(5-(2-arylvinyl)-1,3,4-oxadiazol-2-yl)]-4-chloro-2-R<sup>1</sup>-benzenesulfonamides <b>7</b>&#8722;<b>36</b> as well as (<i>E</i>)-4-[5-styryl1,3,4-oxadiazol-2-yl]benzenesulfonamides <b>47</b>&#8722;<b>50</b> and (<i>E</i>)-2-(2,4-dichlorophenyl)-5-(2-arylvinyl)-1,3,4-oxadiazols <b>51</b>&#8722;<b>55</b>. All target derivatives were evaluated for their anticancer activity on HeLa, HCT-116, and MCF-7 human tumor cell lines. The obtained results were analyzed in order to explain the influence of a structure of the 2-aryl-vinyl substituent and benzenesulfonamide scaffold on the anti-tumor activity. Compound <b>31</b>, bearing 5-nitrothiophene moiety, exhibited the most potent anticancer activity against the HCT-116, MCF-7, and HeLa cell lines, with IC50 values of 0.5, 4, and 4.5 &#181;M, respectively. Analysis of structure-activity relationship showed significant differences in activity depending on the substituent in position 3 of the benzenesulfonamide ring and indicated as the optimal <i>meta</i> position of the sulfonamide moiety relative to the oxadizole ring. In the next stage, chemometric analysis was performed basing on a set of computed molecular descriptors. Hierarchical cluster analysis was used to examine the internal structure of the obtained data and the quantitative structure&#8722;activity relationship (QSAR) analysis with multiple linear regression (MLR) method allowed for finding statistically significant models for predicting activity towards all three cancer cell lines.https://www.mdpi.com/1422-0067/21/6/2235benzenesulfonamidesynthesis1,3,4-oxadiazoleanticancer activityqsarcluster analysis
collection DOAJ
language English
format Article
sources DOAJ
author Krzysztof Szafrański
Jarosław Sławiński
Łukasz Tomorowicz
Anna Kawiak
spellingShingle Krzysztof Szafrański
Jarosław Sławiński
Łukasz Tomorowicz
Anna Kawiak
Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides
International Journal of Molecular Sciences
benzenesulfonamide
synthesis
1,3,4-oxadiazole
anticancer activity
qsar
cluster analysis
author_facet Krzysztof Szafrański
Jarosław Sławiński
Łukasz Tomorowicz
Anna Kawiak
author_sort Krzysztof Szafrański
title Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides
title_short Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides
title_full Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides
title_fullStr Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides
title_full_unstemmed Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides
title_sort synthesis, anticancer evaluation and structure-activity analysis of novel (<i>e</i>)- 5-(2-arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2020-03-01
description To learn more about the structure&#8722;activity relationships of (<i>E</i>)-3-(5-styryl-1,3,4-oxadiazol-2-yl)benzenesulfonamide derivatives, which in our previous research displayed promising in vitro anticancer activity, we have synthesized a group of novel (<i>E</i>)-5-[(5-(2-arylvinyl)-1,3,4-oxadiazol-2-yl)]-4-chloro-2-R<sup>1</sup>-benzenesulfonamides <b>7</b>&#8722;<b>36</b> as well as (<i>E</i>)-4-[5-styryl1,3,4-oxadiazol-2-yl]benzenesulfonamides <b>47</b>&#8722;<b>50</b> and (<i>E</i>)-2-(2,4-dichlorophenyl)-5-(2-arylvinyl)-1,3,4-oxadiazols <b>51</b>&#8722;<b>55</b>. All target derivatives were evaluated for their anticancer activity on HeLa, HCT-116, and MCF-7 human tumor cell lines. The obtained results were analyzed in order to explain the influence of a structure of the 2-aryl-vinyl substituent and benzenesulfonamide scaffold on the anti-tumor activity. Compound <b>31</b>, bearing 5-nitrothiophene moiety, exhibited the most potent anticancer activity against the HCT-116, MCF-7, and HeLa cell lines, with IC50 values of 0.5, 4, and 4.5 &#181;M, respectively. Analysis of structure-activity relationship showed significant differences in activity depending on the substituent in position 3 of the benzenesulfonamide ring and indicated as the optimal <i>meta</i> position of the sulfonamide moiety relative to the oxadizole ring. In the next stage, chemometric analysis was performed basing on a set of computed molecular descriptors. Hierarchical cluster analysis was used to examine the internal structure of the obtained data and the quantitative structure&#8722;activity relationship (QSAR) analysis with multiple linear regression (MLR) method allowed for finding statistically significant models for predicting activity towards all three cancer cell lines.
topic benzenesulfonamide
synthesis
1,3,4-oxadiazole
anticancer activity
qsar
cluster analysis
url https://www.mdpi.com/1422-0067/21/6/2235
work_keys_str_mv AT krzysztofszafranski synthesisanticancerevaluationandstructureactivityanalysisofnoveliei52arylvinyl134oxadiazol2ylbenzenesulfonamides
AT jarosławsławinski synthesisanticancerevaluationandstructureactivityanalysisofnoveliei52arylvinyl134oxadiazol2ylbenzenesulfonamides
AT łukasztomorowicz synthesisanticancerevaluationandstructureactivityanalysisofnoveliei52arylvinyl134oxadiazol2ylbenzenesulfonamides
AT annakawiak synthesisanticancerevaluationandstructureactivityanalysisofnoveliei52arylvinyl134oxadiazol2ylbenzenesulfonamides
_version_ 1725027596241993728